The Orange Pill Podcast

What if your blood could predict your lifespan more accurately than your annual physical?
New research reveals that your fatty acid profile, especially your Omega-3 Index, may be as powerful a predictor of mortality as smoking.
In this episode, we break down the science behind your body’s hidden “fatty acid fingerprint” and why “normal” lab results might be giving you a false sense of security.

The supplement aisle is changing-fast.
In Episode 105, we break down the five biggest shifts redefining wellness by Fall 2026, from personalized nutrition and postbiotics to nootropics, longevity science, and the rise of women’s health as a market powerhouse.
This isn’t about taking more supplements- it’s about taking the right ones, in smarter, more effective ways.
If you want to stay ahead of where the industry (and your health routine) is going, this episode is your roadmap.

Peptides are exploding in popularity-but the rules around them are anything but clear.
In Episode 104, we unpack the growing clash between RFK Jr. and the FDA over peptide regulation, the rise of the gray market, and what this means for safety, access, and the future of clinical innovation.
This isn’t just a policy debate-it’s a turning point for the entire wellness industry.

Vitamin D has long been associated with bone health-but emerging neuroscience suggests its role goes far beyond that.
In this episode, we explore how the so-called “sunshine vitamin” may influence brain structure, cognitive function, and long-term mental health outcomes.
From its role as a neurosteroid regulating hundreds of genes to its connection with depression, ADHD, and dementia risk, the data is beginning to paint a much bigger picture.
We also unpack:✔ Why midlife Vitamin D levels may impact brain health decades later✔ The link between geography, sunlight exposure, and mental health risk✔ The surprising reality of widespread deficiency-even in sunny regions
As research continues to evolve, one question becomes hard to ignore:
Are we underestimating the role of Vitamin D in shaping brain health across the lifespan?

Anxiety is often framed as a psychological condition- but what if part of the story is biological?
Emerging research in nutritional psychiatry is uncovering a consistent metabolic signature in individuals with anxiety: reduced levels of choline in the brain.
In this episode, we explore the science behind this discovery, including:✔ An 8% reduction in brain choline linked to anxiety✔ The role of choline in brain structure, signaling, and resilience✔ Why chronic stress may be depleting key nutrients✔ What this means for future clinical and nutritional strategies
As the line between mental health and metabolism continues to blur, this episode asks a critical question:
Are we overlooking a fundamental nutritional gap in how we approach anxiety?

For decades, cardiovascular care has focused on slowing disease and not reversing it. But new clinical data is challenging that paradigm.
In this episode, we break down emerging evidence showing that high-dose Nattokinase, a fibrinolytic enzyme derived from fermented soy, may do more than support heart health. It may actively reduce arterial plaque.
From a 36% reduction in carotid plaque size to insights into autophagy, inflammation, and the gut-heart axis, this episode explores what these findings really mean and where the science still needs scrutiny.
If you’re working in cardiovascular health, nutraceutical innovation, or clinical research, this is one conversation you don’t want to miss.

100 episodes in and we’re tackling one of the most critical shifts in the industry.
In Episode 100 of the Orange Pill Podcast, we break down recent FDA enforcement actions from CDER’s BIMO program that reveal a hard truth:
Your supplement can become a drug- based on how you study it.
From enrolling diseased populations without an IND to unethical consent practices and compromised data integrity, these cases highlight the increasing scrutiny on clinical trials in the wellness space.
If you’re running or planning a study, this episode isn’t optional listening.

What if the safety data behind a drug… couldn’t be verified?
In Episode 99 of the Orange Pill Podcast, we break down a recent FDA Warning Letter that exposed a troubling “liaison” model, where a contract research company claimed ownership of studies it never actually conducted.
From falsified study directors to missing raw data, this case reveals how gaps in oversight can compromise the very foundation of drug development, and why sponsors can no longer rely on paper compliance alone.

You trust that every ingredient in your food has been reviewed for safety.
But what if no one is actually checking?
In Episode 98 of the Orange Pill Podcast, we unpack the GRAS loophole- a decades-old regulatory pathway that allows companies to self-affirm the safety of food ingredients, often without notifying the FDA.
From legacy additives like BHA to the growing concern around endocrine-disrupting chemicals, this episode explores the transparency crisis shaping today’s food supply, and what “radical transparency” could mean for the future.

By 2050, the world will need to feed 10 billion people.
Traditional food innovation simply isn’t fast enough.
In Episode 97 of the Orange Pill Podcast, we explore how Artificial Intelligence is transforming the way food is discovered, designed, and delivered- from identifying hidden health compounds in plants to predicting taste, texture, and nutrition before a product even reaches the lab.
From precision nutrition to AI-driven ingredient discovery, the future of food may be built not just by farmers and chefs, but by algorithms.